Impact BioMedical, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross
Impact BioMedical, INC. (IBO) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross of 18.04 million shares for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-11.
Financial Statements › Shareholders' Equity › Shares Granted or Issued, Share-Based Payment Arrangement
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross · last filed 2026-03-11
- Impact BioMedical, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2025 was 18.04M shares, a 0.00% change from fiscal 2024.
- Impact BioMedical, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2024 was 18.04M shares, a 3.86% decline from fiscal 2023.
- Impact BioMedical, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2023 was 18.76M shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 12 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 12 month as first filed |
|---|---|---|
| 2025-12-31 | 18.04M shares 10-K · filed 2026-03-11 | |
| 2024-12-31 | 18.04M shares 10-K · filed 2026-03-11 | |
| 2023-12-31 | 18.76M shares 10-K · filed 2026-03-11 | 10.57M shares 10-K · filed 2024-02-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aquestive Therapeutics, Inc. (AQST) | United States | $0.606B | -6.67 |
| CorMedix Inc. (CRMD) | United States | $0.605B | 3.25 |
| CytomX Therapeutics, Inc. (CTMX) | United States | $0.598B | -10.25 |
| Monopar Therapeutics (MNPR) | United States | $0.598B | -34.82 |
| Neurogene Inc. (NGNE) | $0.625B | -4.46 | |
| Altimmune, Inc. (ALT) | United States | $0.593B | -6.43 |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |
| ZEVRA THERAPEUTICS, INC. (ZVRA) | United States | $0.668B | 14.61 |